Use Code 15OFFNEW for 15% Off Your First Order   •   Free Shipping on Orders Over $250   •   Research Use Only

Reta GLP-3

Starting at $129.00

Free Shipping

On orders over $250

Same-Day Shipping

Orders placed before 4 PM EST

Technical Specifications
  • ✓
    Purity: ≥99%
  • ✓
    Testing Method: HPLC
  • ✓
    Form: Lyophilized powder
  • ✓
    Container: 3 mL sterile vial
  • ✓
    Storage: Refrigerated (2–8°C)
  • ✓
    Documentation: Batch COA available

Description

Research Overview

Reta is a triple hormone receptor agonist targeting the GLP-1, GIP, and glucagon (GCG) receptors simultaneously, representing the next generation of incretin-based metabolic research compounds beyond dual agonists. As a 39-amino acid peptide linked to a C20 fatty diacid moiety that extends its pharmacokinetic half-life, Reta is studied for its engagement of three distinct hormonal pathways involved in energy homeostasis.

This triple-receptor activity places Reta at the forefront of metabolic signaling research, enabling investigators to study the additive and synergistic effects of GLP-1, GIP, and glucagon receptor co-activation across a range of metabolic and hepatic research models.

Explore related peptide research in our Research Library, or dive deeper into the full Reta Research Overview. For a comprehensive research profile including mechanism of action and receptor biology, see the Retatrutide Research Overview at Genevium.


Scientific Background

The rationale for triple agonism comes from the complementary roles of the three targeted receptors. GLP-1 receptor activation suppresses appetite signaling and stimulates insulin secretion. GIP receptor activation potentiates the insulin response and modulates adipose tissue biology. Glucagon receptor activation increases energy expenditure and promotes lipolysis.

The glucagon component is especially significant for hepatic research. The liver expresses glucagon receptors but little or no GLP-1 or GIP receptor, so glucagon receptor engagement gives Reta direct effects on hepatic lipid and energy metabolism that dual agonists cannot reach. This has made triple incretin biology one of the most active areas of current metabolic research.


Molecular Information

  • Peptide Type: Triple GIP/GLP-1/Glucagon receptor agonist
  • Amino Acid Length: 39 amino acids (modified GIP backbone with C20 fatty diacid moiety)
  • Primary Targets: GIP receptor, GLP-1 receptor, and Glucagon receptor
  • Research Classification: Triple incretin metabolic research compound

Quality & Compliance

Each batch undergoes analytical verification to confirm identity and purity, and batch-specific Certificates of Analysis (COA) are maintained for every production run. This product is supplied strictly for laboratory research and is not for human or veterinary use.

1 review for Reta GLP-3

  1. Charles Ales (verified owner) –

    Reta has helped me get past my plato of being stuck at a certain weight. Been using it for about 2 months and I have lost between 10 and 12 pounds. For me there really hasn’t been any side effects to report at this time.

Add a review

Your email address will not be published. Required fields are marked *

Pairs Well With

Sign In

New here?  Create an account

Biostrata Research Logo

Age Verification

You must be 21 or older to enter this site. All products are for laboratory research use only and not for human consumption. Products have not been evaluated by the FDA. By clicking “I Agree,” you accept these terms.